Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Rite Aid (RAD)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for RAD as compared to
Top Competitors
Drug Stores
Pharma & Healthcare
Retail
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Comp. Sales Growth
►
1.3%
VERY LOW
Number of Stores
►
5K
VERY LOW
Square Footage
►
50.1M
LOW
Sales per sq. ft
►
486
LOW
Front Store Sales
►
8.05B
AVG
% of Drug Sales Covered by Third Party Insurers
►
95.9%
AVG
Prescriptions Growth
►
1.7%
% of Drug Sales Covered by Third Party I...
Number of Stores
Comparable Sales Growth
Sales per Square Foot
Square Footage
Front Store Sales
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
26.0B
AVG
EBITDA
►
-1.38B
VERY LOW
Net Income
►
-2.77B
VERY LOW
Revenue Growth
►
-1.3%
AVG
Operating Margin
►
-7.6%
VERY LOW
Net Margin
►
-10.6%
VERY LOW
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-6.75
Current Ratio
►
1.83
AVG
Quick Ratio
►
0.361
LOW
Interest Coverage Ratio
►
-4.06
VERY LOW
Book Value Per Share
►
-1.58
Cash Per Share
►
0.136
Loading...
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
VALUATION
Price to Earnings (P/E)
►
-0.504
Price to Book (P/B)
►
-0.989
Price to Sales (P/S)
►
0.0532
VERY LOW
Return on Assets (ROA)
►
-23.6%
VERY LOW
Return on Equity (ROE)
►
-2110.8%
VERY LOW
EV/EBITDA
►
-5.33
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0%
Held by insiders
14.6%
Held by institutions
4.9%